ArticleEuropean journal of nuclear medicine and molecular imaging2023

Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial.

Adrien Holzgreve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.